Author

R. R. Segireddy

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:protein structure prediction· 1 Assay:proteomics· 1 Assay:structural biology· 1 Organism:virus· 1

Frequent Co-Authors

A. Berg· 2 shared A. D. Douglas· 2 shared A. Ahmad· 1 shared A. Douglas· 1 shared C. C. Joe· 1 shared C. Oliveira· 1 shared D. Doultsinos· 1 shared F. Galaway· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Berg

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivFeb 28, 2022

Structure of trimeric pre-fusion rabies virus glycoprotein in complex with two protective antibodies

W. M. Ng, S. Fedosyuk, S. English…·A. D. Douglas

The paper reports the structure of pre-fusion rabies virus glycoprotein complexed with two protective antibodies, showing how they stabilize the protein and provide insights for vaccine design.

DOI 10.1016/j.chom.2022.07.014

structural biologyexperimental assay

𝕏 PostBluesky

BioengineeringbioRxivPreprintDec 22, 2021

Accelerating manufacturing to start large-scale supply of a new adenovirus-vectored vaccine within 100 days

C. C. Joe, R. R. Segireddy, C. Oliveira…·A. Douglas

This paper describes an accelerated manufacturing process for adenovirus-vectored vaccines, enabling large-scale supply within 100 days of pathogen identification.

DOI 10.1101/2021.12.22.473478

experimental assaydrug response / drug discovery

𝕏 PostBluesky

MicrobiologybioRxivFeb 2, 2020

A screen for Plasmodium falciparum sporozoite surface protein binding to human hepatocyte surface receptors identifies novel host-pathogen interactions

R. R. Segireddy, K. Dundas, J. Knoeckel…·A. D. Douglas

The paper identifies novel host-pathogen interactions between Plasmodium falciparum sporozoite proteins and human hepatocyte surface receptors using a high-throughput screening assay.

DOI 10.1186/s12936-024-04913-2

humanvirus

𝕏 PostBluesky